Jin‐Hwan Kwak

1.2k total citations
47 papers, 984 citations indexed

About

Jin‐Hwan Kwak is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Jin‐Hwan Kwak has authored 47 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Infectious Diseases and 15 papers in Molecular Medicine. Recurrent topics in Jin‐Hwan Kwak's work include Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Jin‐Hwan Kwak is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Jin‐Hwan Kwak collaborates with scholars based in South Korea, United States and Canada. Jin‐Hwan Kwak's co-authors include Bernard Weisblum, Hee-Soo Park, Won‐Gon Kim, Sangku Lee, Cheol Min Kim, Jeong Mi Kim, Sang‐Hun Oh, Hong-Seok Kim, Chang‐Ji Zheng and Hyunyul Kim and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jin‐Hwan Kwak

43 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin‐Hwan Kwak South Korea 18 438 196 176 167 158 47 984
J. Spížek Czechia 19 653 1.5× 393 2.0× 206 1.2× 226 1.4× 94 0.6× 64 1.3k
Marina Y. Fosso United States 16 347 0.8× 143 0.7× 169 1.0× 227 1.4× 87 0.6× 24 791
Jiangwei Yao United States 22 676 1.5× 131 0.7× 320 1.8× 143 0.9× 181 1.1× 34 1.3k
Rosario Musumeci Italy 20 294 0.7× 190 1.0× 120 0.7× 236 1.4× 129 0.8× 51 1.1k
Xinxin Hu China 20 464 1.1× 404 2.1× 122 0.7× 223 1.3× 278 1.8× 76 1.1k
J N Hobbs United States 17 539 1.2× 224 1.1× 340 1.9× 124 0.7× 158 1.0× 18 980
Linda Ejim Canada 17 627 1.4× 295 1.5× 373 2.1× 168 1.0× 470 3.0× 19 1.4k
Béatrice Marquez Belgium 11 315 0.7× 130 0.7× 124 0.7× 120 0.7× 167 1.1× 12 828

Countries citing papers authored by Jin‐Hwan Kwak

Since Specialization
Citations

This map shows the geographic impact of Jin‐Hwan Kwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Hwan Kwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Hwan Kwak more than expected).

Fields of papers citing papers by Jin‐Hwan Kwak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin‐Hwan Kwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Hwan Kwak. The network helps show where Jin‐Hwan Kwak may publish in the future.

Co-authorship network of co-authors of Jin‐Hwan Kwak

This figure shows the co-authorship network connecting the top 25 collaborators of Jin‐Hwan Kwak. A scholar is included among the top collaborators of Jin‐Hwan Kwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin‐Hwan Kwak. Jin‐Hwan Kwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Young‐Jin, Jin‐Hwan Kwak, Hyunjoo Pai, et al.. (2023). 2518. Lead optimization on 26-membered thiopeptide antibiotics and identification of pre-clinical candidates against Clostridioides difficile and Staphylococcus aureus for impetigo. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
2.
3.
Son, Young‐Jin, Young‐Rok Kim, Sang‐Hun Oh, et al.. (2022). Micrococcin P2 Targets Clostridioides difficile. Journal of Natural Products. 85(8). 1928–1935. 7 indexed citations
4.
Kim, Bomin, et al.. (2019). Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Scientific Reports. 9(1). 7741–7741. 25 indexed citations
5.
Oh, Sang‐Hun, et al.. (2017). Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens. International Journal of Antimicrobial Agents. 50(6). 700–706. 17 indexed citations
6.
Oh, Sang‐Hun, et al.. (2017). In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus. Molecules. 22(12). 2096–2096. 2 indexed citations
7.
Beck, Bo Ram, Daniel H. Kim, Jin‐Hwan Kwak, et al.. (2016). Distinct immune tones are established by Lactococcus lactis BFE920 and Lactobacillus plantarum FGL0001 in the gut of olive flounder (Paralichthys olivaceus). Fish & Shellfish Immunology. 55. 434–443. 41 indexed citations
8.
Kim, Hong-Seok, et al.. (2013). Synthesis and antimicrobial activity of imidazole and pyridine appended cholestane-based conjugates. Bioorganic & Medicinal Chemistry Letters. 23(15). 4315–4318. 36 indexed citations
9.
Kim, Hong-Seok, et al.. (2013). N-cholesteryl amino acid conjugates and their antimicrobial activities. European Journal of Pharmaceutical Sciences. 50(2). 208–214. 4 indexed citations
10.
Kim, Hong-Seok, et al.. (2011). A concise synthesis and antimicrobial activities of 3-polyamino-23,24-bisnorcholanes as steroid–polyamine conjugates. Bioorganic & Medicinal Chemistry Letters. 21(13). 3861–3865. 10 indexed citations
11.
Lee, Sungwon, Seulmee Shin, Hyunyul Kim, et al.. (2011). Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-κB pathways. Journal of Inflammation. 8(1). 16–16. 108 indexed citations
12.
Kwak, Jin‐Hwan, et al.. (2010). Antimicrobial activity of DW286 against Streptococcus pneumoniae. International Journal of Antimicrobial Agents. 36(3). 230–233. 2 indexed citations
13.
Lee, Hyun‐Hee, et al.. (2010). In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone. Antimicrobial Agents and Chemotherapy. 54(12). 5359–5362. 63 indexed citations
14.
Zheng, Chang Ji, Mi‐Jin Sohn, Sangku Lee, et al.. (2007). Cephalochromin, a FabI-directed antibacterial of microbial origin. Biochemical and Biophysical Research Communications. 362(4). 1107–1112. 36 indexed citations
15.
Kim, Cheol Min, et al.. (2007). Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. Journal of Antimicrobial Chemotherapy. 60(3). 568–574. 58 indexed citations
16.
Kim, Cheol Min, et al.. (2007). Park, H. S. et al. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J. Antimicrob. Chemother. 60, 568-574. 5 indexed citations
17.
Park, Hee-Soo, et al.. (2006). In Vitro and In Vivo Antibacterial Activities of DW-224a, a New Fluoronaphthyridone. Antimicrobial Agents and Chemotherapy. 50(6). 2261–2264. 45 indexed citations
18.
Yoo, Yung–Choon, et al.. (1999). Fermented Extracts of Korean Mistletoe with Lactobacillus (FKM-110) Stimulate Macrophage and Inhibit Tumor Metastasis. Korean Journal of Food Science and Technology. 31(3). 838–847. 4 indexed citations
19.
Kwak, Jin‐Hwan, et al.. (1996). In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum. Journal of Antimicrobial Chemotherapy. 37(4). 711–726. 6 indexed citations
20.
Kim, Hee‐Jin, et al.. (1995). Safety Evaluation of LB20304, a New Quinolone Antibiotic. Biomolecules & Therapeutics. 3(4). 322–326. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Spížek Breakdown of academic impact, for papers by Marina Y. Fosso Breakdown of academic impact, for papers by Jiangwei Yao Breakdown of academic impact, for papers by Rosario Musumeci Breakdown of academic impact, for papers by Xinxin Hu Breakdown of academic impact, for papers by J N Hobbs Breakdown of academic impact, for papers by Linda Ejim Breakdown of academic impact, for papers by Béatrice Marquez
Rankless by CCL
2026